Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-16-008539
Filing Date
2016-11-22
Accepted
2016-11-22 16:23:31
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT s104774_lederman.html 4  
1 OWNERSHIP DOCUMENT s104774_lederman.xml 4 9059
  Complete submission text file 0001615774-16-008539.txt   10567
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Reporting) CIK: 0001563420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 162013464